Inhibitory mechanisms of H+-ATPase inhibitor bafilomycin A1 and carbonic anhydrase II inhibitor acetazolamide on experimental bone resorption  by Yasuo Ohba,  et al.
FEBS 17093 FEBS Letters 387 (1996) 175-178 
Inhibitory mechanisms of H+-ATPase inhibitor bafilomycin A1 
and carbonic anhydrase II inhibitor acetazolamide on 
experimental bone resorption 
Yasuo Ohba a, Tomoko Ohba% Koji Sumitani% Kahori Tagami-Kondoh% Kenji Hiura a, 
Yoshiki Miki a, Hisao Kakegawa b, Teruko Takano-Yamamoto a, Nobuhiko Katunuma b,* 
~Department of Orthodontics, School of Dent&try, Tokushima University, Kuramoto-cho, Tokushima 770, Japan 
bInstitute for Health Sciences, Tokushirna Bunri Unviersity, Yamashiro-cho, Tokushima 770, Japan 
Received 16 April 1996 
Abstract The effects of the vacuolar-type H+-ATPase inhibitor 
baf'domycin AI (baf. At) and the carbonic anhydrase II inhibitor 
acetazolamide (AZ) on bone resorption and procathepsin L 
secretion of rat osteoclasts were investigated using the bone slice 
assay method, pit formation test. Baf. A1 completely suppressed 
osteoclastic bone resorption stimulated by parathyroid hormone 
(PTI-I), but did not affect procathepsin L secretion, while AZ 
suppressed both bone resorption and procathepsin L secretion. 
These findings suggest hat bone resorption by procathepsin L 
secretion and its processing are regulated by proton production 
and proton secretion. 
K,'3: words: Procathepsin L; Bone resorption; 
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[1,2,15]. The secreted procathepsin L appears to be converted 
to its active mature form, cathepsin L, in the lacuna [16]. 
However, the regulatory mechanisms of procathepsin L secre- 
tion from osteoclasts are still unclear. 
The secretion of both protons and procathepsin L is indis- 
pensable for osteoclastic bone resorption. In the present 
study, in order to clarify whether procathepsin L secretion 
is influenced by proton pumping and/or proton production 
in osteoclasts, the secretion of procathepsin L into the med- 
ium of the bone slice culture was assayed. Pit formation was 
arrested by administration of the vacuolar-type H+-ATPase 
inhibitor bafilomycin A1 (baf. A1) and also the CAII inhibitor 
acetazolamide (AZ). 
2. Materials and methods 
1. Introduction 
Bone resorption depends on the secretion of protons and 
l:~ ;osomal proteinases from osteoclasts into the extracellular 
m tcroenvironment (Howship's lacuna) under their ruffled bor- 
&r [1,2]. In osteoclasts, protons are generated by carbonic 
aJ~hydrase II (CAII) [3,4] and actively transported by the pro- 
tc, n pump driven by vacuolar-type H+-ATPase at the ruffled 
b,,rder into the lacuna [5], which participate in bone resorp- 
ti,m. The lysosomal proteinases, possibly cysteine proteinases, 
h,~d been thought o play an important role in osseous col- 
lagenolysis [2,6-11] and protons may assist he protease secre- 
ti,)n. The secretion of protons and lysosomal proteinases may 
pay an essential role in the bone resorption mechanism. Dur- 
iv~g osteoclastic bone resorption, it is possible that removal of 
c~ lcium precedes the degradation of the bone matrix collagen 
[2,12]. 
We previously reported that the bone pit formation stimu- 
l~ted by PTH was significantly suppressed by specific inhibi- 
t~ rs of cathepsin L and L-type proteinases, but not by those 
oi" cathepsins B and D [13]. It was also demonstrated using 
b,)ne slice assays that an increase in pit formation occurs in 
parallel with the secretion of procathepsin L induced by PTH 
aad that both increases were completely inhibited by the ad- 
dition of calcitonin [14]. These findings suggest hat pro- 
c;tthepsin L is secreted from osteoclasts indirectly stimulated 
b': PTH, and plays an important role in PTH-induced bone 
r~sorption. Procathepsin L is synthesized in the endoplasmic 
r~ticulum (ER), transported into the Golgi system and then 
s~creted into the lacuna via the ruffled border membrane 
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2.1. Materials 
Baf. A1 and AZ were purchased from Wako Pure Chemical (Osaka, 
Japan). Rabbit anti-rat cathepsin L was donated by Dr. E. Kominami 
(Department ofBiochemistry, Juntendo University, Tokyo, School of 
Medicine, Japan). Human PTH (1-34) was obtained from Peninsula 
Laboratories, Inc. (Belmond, CA). Sprague-Dawley (SD) rats (1-2 
days old) came from Charles River, Japan. 
2.2. Assay of bone resorption (Pit formation test) 
Bone resorption was assayed according to the method of McSheehy 
and Chambers [17] with modifications a described indetail previously 
[13,14,16]. Unfractionated bone cells were prepared from tibiae, fe- 
mora, and humeri of l-2-day-old SD rats. The bones were dissected 
free of soft tissues in iced tissue culture medium (pH 7.2) [alpha- 
minimum essential medium (c~-MEM) (Dainippon Pharmaceutical 
Co., Japan) supplemented with 100 IU per ml benzylpenicillin] con- 
taining 10 mM HEPES. For preparation ofbone cells the long bones 
were minced with scissors in the same medium, and then the suspen- 
sion was triturated. 250 Ixl of the cell suspension (4× 106 cells per ml) 
was allowed to settle onto a bovine cortical bone slice (400-~tm thick 
circle, 6 mm in diameter) ineach well of a 96-well plate. After 1 h of 
incubation at 37°C in a CO2 incubator, unattached cells were washed 
away with c~-MEM, and bone slices with attached cells were trans- 
ferred to fresh medium containing various concentrations of inhibitors 
and 10 -7 M PTH and then incubated for 24-72 h. Osteoclast-induced 
pits on the slices were stained with acid hematoxylin for 5 min. The 
total area of pits was measured under an optical microscope. 
2.3. Observation of osteoclasts on slices 
Observation of osteoclasts on slices was made following tartrate- 
positive acid phosphatase (TRAP) staining according to Akatsu et al. 
[18]. The cells were washed with phosphate-buffered saline (PBS, pH 
7.4), and then fixed with 10% formalin in PBS for 10 min. After 
treatment with ethanol-acetone (50:50, v/v) for 1 min, the slice surface 
with cells was dried and stained for TRAP, The cells were observed 
under an optical microscope. 
2.4. Electrophoresis and Western blotting analysis 
SDS-polyacrylamide gel electrophoresis was carried out according 
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to the method of Laemmli [19]. For Western blotting analysis the 
medium did not contain fetal bovine serum. In the experiment utiliz- 
ing baf. A], the media were collected at 72 h after addition of PTH 
and baf. A1 and concentrated 100 times. Samples were resolved by 
SDS-PAGE in a 15 25% gradient gel and electrophoretically trans- 
ferred to a nitrocellulose blotting membrane (Millipore). Immunoblot- 
ting for detection of 39-kDa procathepsin L was conducted with rab- 
bit anti-rat cathepsin L as the primary antibody, and the bound 
antibodies were detected with goat anti-rabbit IgG-conjugated alka- 
line phosphatase (E'Y Laboratories, Inc.). The alkaline phosphatase 
reaction was performed with a Picoblue Immunoscreening Kit (Stra- 
tagene, CA). The SDS-PAGE low-range standards (Bio-Rad, Rich- 
mond) used as molecular weight markers were BSA (80 kDa), oval- 
bumin (49.5 kDa), carbonic anhydrase (32.5 kDa), soybean trypsin 
inhibitor (27.5 kDa), and lysozyme (18.5 kDa). In the experiment with 
AZ, the media were collected at 72 h after addition of PTH and AZ 
and concentrated 30 times. Samples were electrophoresed in a SDS- 
12.5% polyacrylamide g l and transferred electrophoretically to a ni- 
trocellulose blotting membrane. The membrane was probed with the 
primary antibody and then with a biotinylated onkey anti-rabbit Ig 
whole antibody (Amersham). Following incubation with streptavidin- 
horseradish peroxidase (Amersham), the blots were developed by the 
enhanced chemiluminescence m thod (Amersham) and then exposed 
to Polaroid type T667 film (Polaroid) that had been loaded into an 
ECL Mini-camera (Amersham). The biotinylated SDS-PAGE broad- 
range standards (Bio-Rad) used as molecular weight markers were 
myosin (200 kDa), I~-galactosidase (116.25 kDa), phosphorylase b 
(97.4 kDa), BSA (66.2 kDa), ovalbumin (45 kDa), carbonic anhydrase 
(31 kDa), soybean trypsin inhibitor (21.5 kDa), lysozyme (14.4 kDa), 
and aprotinin (6.5 kDa). 
2.5. Statistical analysis 
Statistical comparison between groups was performed by the 
Mann-Whitney U-test. 
3. Results and discussion 
The present study was performed in order to clarify the 
inter-related regulation between proton and procathepsin L
secretion from osteoclasts. Baf. A1 inhibited osteoclastic 
bone resorption by blocking vacuolar-type H+-ATPase in 
the ruffled border membrane [20]. As shown in Fig. 1, PTH- 
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Fig. 1. Inhibitory effect of baf. A1 on pit formation induced by 
PTH. Cells were stimulated with PTH at a concentration of 10 -7 
M. Each value of bone resorption indicates the mean+S.E.M. 
*p < 0.05, vs. value for PTH alone. Before staining of the resorption 
pits, the number of osteoclasts per bone slice was counted. The 
number for PTH, PTH plus 0.1, or 1 ng/ml of baf. A1 treatment 
was 111 _+ 16, 121 +5, or 90+ 12, respectively. 
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Fig. 2. (A) Effect of baf. A1 on procathepsin L secretion. Lanes: 1, 
untreated group; 2, PTH group; 3, PTH and bat'. Ai group. Con- 
centrations of PTH and baf. A 1 were 10 -7 M and 1 ng/ml, respec- 
tively. The media were collected at 72 h after addition of PTH and 
baf. A1, concentrated 100 times, and subjected to SDS-PAGE. (B) 
Pit formations under the same conditions as those in (A). Bone re- 
sorption was assayed according to the method described in Section 
2. Each value indicates the mean + S.E.M. *p < 0.05, **p < 0.01 ; vs. 
value for PTH alone. The number of osteoclasts per bone slice was 
6 + 3 and 12 + 6 in the treatment with PTH and PTH plus baf. A~, 
respectively. 
enhanced bone resorption was suppressed by baf. A1 in a 
dose-dependent manner at concentrations of 0.1 and 1 ng/ 
ml. The number of osteoclasts per bone slice was not signifi- 
cantly affected by baf. A~ at concentrations less than 1 ng/ml 
(Fig. 1), suggesting no toxicity in this range. When the proton 
pump was specifically inhibited by baf. A1 treatment, we 
measured the amount of procathepsin L secreted into the 
culture medium using Western blotting analysis. Although 
sufficient baf. A1 (1 ng/ml) was added, the amount of 39- 
kDa procathepsin L secreted was not inhibited as shown in 
Fig. 2A, whereas complete inhibition of bone resorption was 
observed for the same dose (Fig. 2B). These findings suggest 
that procathepsin L seeretion is independent of proton trans- 
port and baf. A1 addition inhibits the conversion of pro- 
cathepsin L to the mature form in the lacuna. Then, to in- 
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Fg. 3. Inhibitory effect of AZ on pit formation induced by PTH. 
C~lls were stimulated by PTH at a concentration of 10 -z M. Each 
wdue of bone resorption indicates the mean + S.E.M. *p < 0.01, vs. 
wdue for PTH alone. The number of osteoclasts per bone slice was 
7 ~_4, 8_+4, 5_+2 or 13_+2 in the treatment with PTH, PTH plus 
1, 6, 10-5 or  10 -4  M AZ, respectively. 
v,.stigate whether proton production positioned upstream of 
t ie  proton pump is associated with procathepsin L secretion, 
e assayed procathepsin L secretion under inhibition of pro- 
t~ ~n production by AZ. AZ treatment markedly reduced PTH- 
e thanced procathepsin L secretion into the culture medium as 
s~Lown in Fig. 4A. Therefore, procathepsin L secretion is as- 
s~,ciated with proton production in the osteoclasts, but not 
ith proton transport. The inhibitory effects on bone resorp- 
t'gn by AZ have previously been reported [21-24], and the 
p'esent study has developed this effect in more detail on the 
c.)rrelation with procathepsin L secretion. AZ treatment re- 
salted in a significant decrease in PTH-induced bone resorp- 
ton  at a concentration of 10 -4 M, and did not influence the 
r amber of osteoclasts on the slices as shown in Figs. 3 and 
4{3. 
The mechanism by which AZ prevents procathepsin L se- 
c "etion is unclear. Hall et al. [23] reported that the release of 
1. sosomal enzyme ~-glucuronidase and protein synthesis tim- 
t~lated by PTH were inhibited by AZ in mouse half-calvaria, 
saggesting the possibility of alteration of hormonally stimu- 
1; .ted bone cell metabolism. Accordingly, the decrease in pro- 
tthepsin L secretion may be influenced by the response to 
trious intracellular signals by the inhibition of proton pro- 
~ uction by AZ. 
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